Global Collaboration Action for Research on Existing Malaria Therapeutics and Clinical Development of New Antimalarial Candidates
Funds clinical trials advancing new or improved antimalarial drug combinations toward registration and access in sub-Saharan Africa.
Unlike the standard Horizon Europe scoring pattern, this topic's second-stage full proposals use a 4/4/3 threshold: Excellence and Impact each need at least 4 out of 5, but Implementation only needs 3, with the three scores combined needing to reach at least 12 out of 15. Contributions from contributing partners feed directly into both the Impact and the Implementation scores, not just into the bu…
This topic wants research consortia to run Phase 2a-or-later clinical trials on new combinations of approved or novel antimalarial candidates, targeting children, pregnant women and immune-compromised people in high-transmission sub-Saharan African regions. It excludes prophylactic vaccine and monoclonal antibody development, and expects proposals to also cover long-term effectiveness data, pharmacovigilance, or evidence on drug resistance, with a clear path to regulatory approval and affordable access.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up
Guides for this application
All guides →Horizon Europe Grants for Startups: A Founder Guide
A practical guide to Horizon Europe grants for startups, including EIC, consortia, eligibility, Funding & Tenders, TRL, budgets, and EU strategy.
Where to applyGrants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
Write proposalHow to Write a Grant Proposal Reviewers Can Score
Learn how to write a grant proposal around reviewer criteria, evidence, work packages, budget logic, and commercialization for deeptech and R&D funding.
DocumentsGrant Work Plan Template: Work Packages, Gantt, Milestones, and Risks
Use this grant work plan template to structure work packages, tasks, owners, deliverables, Gantt timing, dependencies, and risk registers.
More from EDCTP3
All grants from this funder →Accelerating the Development of Prophylactic Vaccines Against Neglected Tropical Diseases (NTDs) in Sub-Saharan Africa
🇪🇺EDCTP3 · European Union
Funds clinical trials of prophylactic vaccines against neglected tropical diseases such as schistosomiasis, leishmaniasis and leprosy in sub-Saharan Africa.
Dr Pascoal Mocumbi Prize
🇪🇺EDCTP3 · European Union
Awards EUR 50,000 to one scientist recognised for advancing clinical development of products for poverty-related diseases in Africa.
Enhancing integrated research and healthcare in sub-Saharan Africa through digital innovation and Artificial Intelligence
🇪🇺EDCTP3 · European Union
Funds coordination projects that scale up validated digital health and AI tools across national or sub-regional health systems in sub-Saharan Africa.
Global Collaboration Action for Prevention and Treatment of Lower Respiratory Tract Infections (LRTIs) in Sub-Saharan Africa
🇪🇺EDCTP3 · European Union
Funds late-stage clinical trials of vaccines, monoclonal antibodies and antivirals against a named list of lower respiratory tract infection pathogens in sub-Saharan Africa.
Global Collaboration Action for Strengthening the Regional Networks of Excellence and Epidemic Preparedness Consortia
🇪🇺EDCTP3 · European Union
Funds 4 regional research networks in sub-Saharan Africa to run multi-country clinical trials and rapid outbreak-response research.
Global collaboration action for the development of TB drugs for therapy and chemoprophylaxis in adults and children in sub-Saharan Africa
🇪🇺EDCTP3 · European Union
Funds Phase IIa-and-later clinical trials of new or shorter TB drug and chemoprophylaxis regimens for adults and children in sub-Saharan Africa.
Similar grants
Browse the directory →
Clinical Research for Common Cancers
🇪🇺European Commission · European Union
Funds €7–10M programmes that bring better cancer diagnosis and treatment trials to patients across four or more European countries.
Clinical trials for advancing innovative interventions for neurodegenerative diseases
🇪🇺European Commission · European Union
Funds early clinical trials of safer, more effective interventions for non-rare neurodegenerative diseases.
Mission Soil and Cancer: Living Labs for Carcinogenic Contamination
🇪🇺European Commission · European Union
Funds two €12M projects using living labs to remediate carcinogenic soils and trace cancer risks through people, food, water and air.
Horizon Health: Antibody Therapies for Emerging Viruses
🇪🇺European Commission · European Union
Funds €9–10M projects that turn monoclonal antibodies into prevention and treatment options for one emerging virus.
Novel Small-Molecule Antivirals for Epidemic-Potential Pathogens
🇪🇺European Commission · European Union
Funds small-molecule antivirals that expand preparedness and treatment options for future viral epidemics and pandemics.
Horizon Health: Bio-printing for Regenerative Medicine
🇪🇺European Commission · European Union
Funds €7–10M projects that advance living-cell bio-printing from laboratory proof toward regenerative medicine.